Massivemarkets

NYSE: MANE · Listed Feb 4, 2026

Veradermics IPO

IPO price

$17.00

Veradermics (MANE) priced its IPO at $17.00 a share and has traded on NYSE since Feb 4, 2026.

MANE today$125.99+641.12%since IPO15-min delayed · as of 6:13:12 AM EST on Nov 19, 2026

See the MANE quote

First trading day · Feb 4, 2026

IPO price 17.00VWAP 36.57first trade 34.00+100.00% from the IPO pricehigh 39.76$37.77volume · rising bars above the line, falling bars below101.46K1:254:00
IPO price
$17.00
above the range of $14 to $16
First trade
$34.00
+100.00% from the IPO price
First-day last trade
$37.77
+122.18% from the IPO price, regular session
Raise
$256.32M
before the underwriters' option

These numbers are from the first trading day, Feb 4, 2026.

How MANE did against the market

MANE against the market, from its first trade at 1:25 ET to the last trade of the session.

MANE from its first trade
+11.09%
Against the market (QQQ)
+10.6 pts

MANE rose 11.1% from its first trade to the last trade of the session. That is 10.6 points better than the market.

Same-day moves do not show that MANE caused them. The market is QQQ, the Nasdaq-100 ETF.

The debut race

MANE against other big listings, as the percent change from each stock's own IPO price.

The first 30 trading days. Each point is the last regular-session trade of a day.

+50%+100%+150%+200%+250%IPOday 1day 5day 10day 15day 20day 25day 30Figma '25 +69.64%Reddit '24 +40.32%CoreWeave '25 +28.42%Arm '23 -3.06%Klarna '25 -7.33%MANE +247.00%

The IPO scoreboard

MANE against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.

MANE against other big IPOs: the money raised, and the return from each IPO price at the first trade, at the last trade of day 1, and on day 5 and day 30.
IPORaisedFirst tradeDay 1 closeDay 1 close, as a barDay 5Day 30
Veradermics '26$256.32M+100.00%+122.18%+140.00%+247.00%
Figma '25$1.22B+157.58%+252.42%+173.64%+69.64%
Circle '25$1.05B+122.58%+168.45%+278.18%+622.98%
Reddit '24$748M+38.24%+47.97%+69.90%+40.32%
Arm '23$5.23B+10.00%+23.76%+3.63%-3.06%
Klarna '25$1.37B+30.00%+16.14%+13.73%-7.33%
CoreWeave '25$1.5B-2.50%+0.02%+34.32%+28.42%

Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.

The offering

The Veradermics IPO offers 15.08M shares to raise $256.32M, before any underwriters' option.

$12$14$15$16$18
Expected price range
$14 to $16
IPO price
$17.00
Shares offered
15.08M
Money raised
$256.32M
Listing date
Feb 4, 2026
Exchange
NYSE
Security
Ordinary Shares

Money raised, against the largest IPOs

  • Alibaba '14$21.77B
  • Facebook '12$18.41B
  • Rivian '21$11.93B
  • Uber '19$8.1B
  • Arm '23$5.23B
  • Veradermics$256.32M

Where MANE ranks

Veradermics's market cap against the largest US-listed companies.

Market cap, against the largest US-listed companies

  • AAPL$5.12T
  • MSFT$3.77T
  • NVDA$3.65T
  • GOOGL$3.47T
  • AMZN$2.9T
  • TSM$1.88T
  • AVGO$1.69T
  • META$1.58T
  • TSLA$1.52T
  • BRK.B$1.22T
  • MANE$5.27B

Filings and the company

What Veradermics has disclosed to the SEC, and the basic facts about the listing.

8-K filings

Material events that Veradermics discloses to the SEC on Form 8-K.

  • Quarterly earningsNov 10, 2026

    On November 10, 2026, Veradermics, Incorporated issued a press release announcing its financial results for the quarter ended September 30, 2026.

  • At Month 12 of treatment with VDPHL01, 89.1% of participants in the BID dose arm and 79.8% of participants in the QD dose arm reported visible improvement in hair coverage on the Androgenetic Alopecia Impact Rating Scale (AAIRS). Additionally, 68.0% of participants in the BID dose arm and 48.4% of participants in the QD dose arm achieved 'improved' or 'much improved' hair coverage on the AAIRS.

  • Business updateOct 19, 2026

    On October 19, 2026, Veradermics, Incorporated issued a press release announcing positive topline data from the Phase 3 clinical trial, Study '304' evaluating VDPHL01 in males with mild-to-moderate pattern hair loss.

  • Investor presentationJul 15, 2026

    A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and the presentation the Company presented on the conference call and webcast is furnished as Exhibit 99.2 to this Current Report on Form 8-K, and both are incorporated by reference herein.

  • Public offeringMay 1, 2026

    On May 1, 2026, Veradermics, Incorporated (the "Company") closed its underwritten public offering (the "Public Offering") of 3,843,790 shares of the Company's common stock, par value $0.00001 per share (the "Common Stock"), at a public offering price of $100.00 per share, pursuant to the Company's registration statements on Form S-1 (File Nos. 333-295356 and 333-295420). In addition, the Company has granted the underwriters an option for a period of 30 days to purchase up to an additional 576,568 shares of Common Stock at the public offering price, less underwriting discounts and commissions.

About Veradermics

Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.

Ticker
MANE
Exchange
NYSE
Market
stocks
Type
CS
Currency
USD
Industry
PHARMACEUTICAL PREPARATIONS
Employees
21
Listed
Feb 4, 2026
Security
Ordinary Shares
Company website

Frequently asked questions

What was the Veradermics IPO price?

$17.00 a share.

When did Veradermics go public?

Veradermics listed on NYSE on Feb 4, 2026 under the ticker MANE.

How much did the Veradermics IPO raise?

$256.32M, before any underwriters' option.

How did Veradermics open on its first day?

MANE first traded at $34.00, +100.00% from the IPO price of $17.00.

How did MANE close on its first day?

Its last regular-session trade was $37.77, +122.18% from the IPO price of $17.00.

What was the MANE first-day trading range?

$32.00 to $40.01 in the regular session.

How many MANE shares traded on the first day?

3.14M shares in the regular session.

How many shares did Veradermics sell in its IPO?

15.08M shares.

How did MANE do against the market on its first day?

MANE rose 11.1% from its first trade to the last trade of the session. That is 10.6 points better than the market (QQQ, the Nasdaq-100 ETF).

What exchange is MANE listed on?

Veradermics lists on NYSE under the ticker MANE.

Build with Massive

Get the MANE data behind this page

The Massive endpoint behind each section of this page
What the page showsEndpoint
Offering terms and dates/vX/reference/ipos
Price/v3/snapshot
Chart, VWAP, and the market comparison/v2/aggs/ticker/MANE/range/5/minute
Market cap/v3/reference/tickers/MANE
News/v2/reference/news
Filings/vX/disclosures

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.